ISIN | IE00BKY80X27 |
---|---|
Valorennummer | 110728313 |
Bloomberg Global ID | |
Fondsname | New Capital Healthcare Disruptors Fund GBP Acc |
Fondsanbieter |
EFG - New Capital
EFG Asset Management (UK) Ltd Park House, 116 Park Street London, W1K 6AP, United Kingdom Telefon: +44 207 173 8011 E-Mail: enquiries@newcapital.com |
Fondsanbieter | EFG - New Capital |
Vertreter in der Schweiz |
CACEIS (Switzerland) SA Nyon Telefon: +41 22 360 94 00 |
Distributor(en) |
EFG Bank AG Zürich |
Anlagekategorie | Obligationenfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Irland |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade across all market capitalizations. The Sub-Fund may invest up to a maximum of 20% of the Net Asset Value in non-US companies including up to 10% of its assets in securities of emerging market issuers. |
Besonderheiten |
Aktueller Preis * | 91.48 GBP | 14.01.2025 |
---|---|---|
Vorheriger Preis * | 93.17 GBP | 13.01.2025 |
52 Wochen Hoch * | 96.08 GBP | 19.09.2024 |
52 Wochen Tief * | 83.05 GBP | 19.04.2024 |
NAV * | 91.48 GBP | 14.01.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 60'561'592 | |
Anteilsklassevermögen *** | 330'311 | |
Trading Information SIX |
YTD-Performance | +2.73% |
31.12.2024 - 14.01.2025
31.12.2024 14.01.2025 |
---|---|---|
YTD-Performance (in CHF) | +0.81% |
31.12.2024 - 14.01.2025
31.12.2024 14.01.2025 |
1 Monat | -1.65% |
16.12.2024 - 14.01.2025
16.12.2024 14.01.2025 |
3 Monate | -1.92% |
14.10.2024 - 14.01.2025
14.10.2024 14.01.2025 |
6 Monate | +3.70% |
15.07.2024 - 14.01.2025
15.07.2024 14.01.2025 |
1 Jahr | +7.80% |
16.01.2024 - 14.01.2025
16.01.2024 14.01.2025 |
2 Jahre | +16.51% |
17.01.2023 - 14.01.2025
17.01.2023 14.01.2025 |
3 Jahre | -2.31% |
14.01.2022 - 14.01.2025
14.01.2022 14.01.2025 |
5 Jahre | -8.52% |
18.05.2021 - 14.01.2025
18.05.2021 14.01.2025 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Natera Inc | 5.91% | |
---|---|---|
argenx SE ADR | 5.73% | |
Intuitive Surgical Inc | 4.88% | |
Veracyte Inc | 4.87% | |
Veeva Systems Inc Class A | 4.29% | |
Align Technology Inc | 4.22% | |
Doximity Inc Class A | 4.06% | |
Stryker Corp | 3.97% | |
Ultragenyx Pharmaceutical Inc | 3.77% | |
IDEXX Laboratories Inc | 3.72% | |
Letzte Daten-Aktualisierung | 31.12.2024 |
TER | 1.0078% |
---|---|
Datum TER | 30.06.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
Datum SRRI *** |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |